1-18 of 18
| Supplier | Product name | Cat.no. | Pack size | Price | ||
|---|---|---|---|---|---|---|
 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)], Human IgA1, kappa | Ab00103-16.0-Conj | Inquire | |||
|
|
Anti-TNF alpha [cA2 (Infliximab)], Human IgA1, kappa | Ab00146-16.0-Conj | Inquire | |||
|
|
Anti-Spike Protein (RBD) [CV30], Human IgA1, kappa | Ab02019-16.0-Conj | Inquire | |||
|
|
Anti-CD44 [Hermes-1], Human IgA1, kappa | Ab00628-16.0-Conj | Inquire | |||
|
|
Anti-Covid-19 & SARS-CoV Nucleocapsid [1C7C7], Human IgA1, kappa | Ab02325-16.0-Conj | Inquire | |||
|
|
Anti-Spike protein [4A8], Human IgA1, kappa | Ab02743-16.0-Conj | Inquire |
1-18 of 18
Customer Support
T +41 41 420 96 36
info@lucerna-chem.ch
Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00
Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch
Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern
© Copyright 2021 Lucerna-Chem AG, Switzerland